John T. Treace
Disclosed holdings of John T. Treace as of 2026-08-24: 7.40M shares of Treace Medical Concepts (TMCI), worth about $28.7M at the last close. In 12 months…
What John T. Treace reported holding
As of the latest filing on , John T. Treace reported holding 7,404,383 shares of Treace Medical Concepts (TMCI), worth about $28.7M at the last close of $4 (Oct 19, 2026). In the last 12 months, John T. Treace bought $1.24M in 12 open-market purchases.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Treace Medical Concepts TMCI | 7,404,383 | 7.40M direct | $4 | $28.7M | Aug 24, 2026 |
Is this John T. Treace’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Insider buying and selling since 2021
John T. Treace bought shares on the open market in 2022, 2024, 2025 and 2026. Sales in 2 of the 6 years since 2021.
John T. Treace reported 26 open-market purchases and 27 sales since 2021; purchases in 4 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | 12×12 trades | — |
| 2025 | 1×1 trade | — |
| 2024 | 7×7 trades | — |
| 2023 | — | 1×1 trade |
| 2022 | 6×6 trades | — |
| 2021 | — | 26×26 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
The company behind these filings
- Treace Medical Concepts TMCI
John T. Treace reported 26 open-market purchases and 27 sales here, 2021 to 2026.
- Market value
- $252M
- Last close
- $3.88
- 12 months
- −39.8%
- Against the S&P 500
- −55.1 pts
- Net margin
- -27.7%
- Revenue (last year)
- $213M
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Free account: get the written context of this page. Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about John T. Treace's trades
Has John T. Treace bought shares on the open market?
John T. Treace bought shares on the open market in 2022, 2024, 2025 and 2026. Sales in 2 of the 6 years since 2021.
When did John T. Treace last buy or sell shares?
In SEC filings since 2021: the latest open-market purchase is from 2026; the latest open-market sale is from 2023.
Which companies has John T. Treace traded as an insider?
Treace Medical Concepts (TMCI), from 2021 to 2026: 26 purchases and 27 sales.